People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

62.84USD
4:01pm EDT
Price Change (% chg)

$0.31 (+0.50%)
Prev Close
$62.53
Open
$62.44
Day's High
$62.94
Day's Low
$62.28
Volume
700,590
Avg. Vol
1,285,649
52-wk High
$63.38
52-wk Low
$47.53

Search Stocks

Runge, Marschall 

Brief Biography

Dr. Marschall S. Runge, M.D., Ph.D., has been appointed as Independent Director of Eli Lilly and Company effective September 1, 2013. Dr. Runge is the Executive Dean for the School of Medicine at the University of North Carolina at Chapel Hill. In his role as Executive Dean for the UNC School of Medicine, Dr. Runge provides overall academic and clinical leadership for the School of Medicine and the UNC Health Care System. In addition to being the Chair of the Department of Medicine, Dr. Runge is also Principal Investigator and Director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at UNC-Chapel Hill, where he has financial, human resource and strategic oversight responsibilities for the program. An honors graduate of Vanderbilt University with a B.A. in Biology and a Ph.D. in molecular biology, Dr. Runge earned his M.D. from the Johns Hopkins School of Medicine, where he was an intern and resident in internal medicine. He then completed a cardiology fellowship at Harvard's Massachusetts General Hospital and was a faculty member there prior to moving to Emory University as an Associate Professor of Medicine in 1989. Before joining the UNC faculty in 2000, Dr. Runge held the John Sealy Distinguished Centennial Chair in Internal Medicine and was Director of the Division of Cardiology and the Sealy Center for Molecular Cardiology at the University of Texas Medical Branch at Galveston. In addition to serving as a member of the Experimental Cardiovascular Sciences Study Section of the National Institutes of Health, Dr. Runge also has published over 150 peer-reviewed manuscripts.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter

11,217,000

Derica Rice

5,176,820

Maria Crowe

--

Jan Lundberg

4,774,540

Melissa Barnes

--

Michael Harrington

3,174,220
As Of 30 Dec 2013
Search Stocks